Progress in Neuropsychopharmacology & Biological Psychiatry Characterisation of methylphenidate-induced excitation in midbrain dopamine neurons, an electrophysiological study in the rat brain

: Methylphenidate (MPH) is a drug routinely used for patients with attention deficit and hyperactivity disorder (ADHD). Concerns arise about psychostimulant use, with dramatic increases in prescriptions. Besides, antipsychotic drugs are often administered in combination with MPH. In this study, we examine the consequences of MPH exposure in combination with dopamine D 2 receptor antagonism (eticlopride) on midbrain dopaminergic neurons in anaesthetised rodents, using in vivo extracellular single-cell electrophysiology. As expected, we show that methylphenidate (2 mg/kg, i.v.) decreases the firing and bursting activities of ventral tegmental area (VTA) dopamine neurons, an effect that is reversed with eticlopride (0.2 mg/kg, i.v .). However, using such a paradigm, we observed higher firing and bursting activities than under baseline conditions. Furthermore, we demonstrate that such an effect is dependent on dual alpha-1 and dopamine D 1 receptors, as well as glutamatergic transmission, through glutamate N-Methyl-D-aspartate (NMDA) receptor activation. Chronic MPH treatment during adolescence greatly dampens MPH-induced excitatory effects measured at adulthood. To conclude, we demonstrated here that a combination of methylphenidate and a dopamine D 2 receptor antagonist produced long-lasting consequences on midbrain dopamine neurons, via glutamatergic-dependent mechanisms.

[1]  C. Jiménez-Rivera,et al.  Alpha-1 Adrenergic Receptors Modulate Glutamate and GABA Neurotransmission onto Ventral Tegmental Dopamine Neurons during Cocaine Sensitization , 2020, International journal of molecular sciences.

[2]  Elyssa B. Margolis,et al.  Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat , 2018, The Journal of comparative neurology.

[3]  A. Omoloye,et al.  Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function , 2018, Journal of psychopharmacology.

[4]  T. Banaschewski,et al.  Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder. , 2018, Journal of child and adolescent psychopharmacology.

[5]  I. S. Esin,et al.  Myasthenia Gravis Attack after Oral Risperidone Treatment: A Case Report. , 2018, The Eurasian journal of medicine.

[6]  W. Shi,et al.  Methylphenidate significantly alters the functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area , 2018, Neuropharmacology.

[7]  N. Dafny,et al.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats. , 2017, Journal of neurophysiology.

[8]  Daniel J. Chandler,et al.  Noradrenergic Modulation of Cognition in Health and Disease , 2017, Neural plasticity.

[9]  N. Dafny,et al.  Methylphenidate modulates dorsal raphe neuronal activity: Behavioral and neuronal recordings from adolescent rats , 2017, Brain Research Bulletin.

[10]  A. Grace Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression , 2016, Nature Reviews Neuroscience.

[11]  J. Millichap,et al.  Dystonia with MPH/Risperidone Combined Therapy for ADHD , 2016, Pediatric neurology briefs.

[12]  B. Lambolez,et al.  A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine , 2015, Scientific Reports.

[13]  M. Miceli,et al.  Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors , 2015, Psychopharmacology.

[14]  C. Paladini,et al.  Generating bursts (and pauses) in the dopamine midbrain neurons , 2014, Neuroscience.

[15]  Boris S. Gutkin,et al.  Mechanisms for multiple activity modes of VTA dopamine neurons , 2014, bioRxiv.

[16]  J. Azorin,et al.  Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report , 2014, Neuropsychiatric disease and treatment.

[17]  A. Grace,et al.  The Infralimbic Cortex Bidirectionally Modulates Mesolimbic Dopamine Neuron Activity via Distinct Neural Pathways , 2013, The Journal of Neuroscience.

[18]  L. Rojas,et al.  Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons , 2015, Neuropharmacology.

[19]  H. Pontén,et al.  The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex , 2013, Journal of Neural Transmission.

[20]  B. Waterhouse,et al.  Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons , 2012, Biological Psychiatry.

[21]  A. Grace,et al.  Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons , 2012, Trends in Neurosciences.

[22]  N. Dafny,et al.  Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats. , 2012, European journal of pharmacology.

[23]  P. Piazza,et al.  Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo. , 2012, Journal of pharmacological and toxicological methods.

[24]  Natalia del Campo,et al.  The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.

[25]  A. Ettenberg,et al.  Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats , 2011, Psychopharmacology.

[26]  D. Lodge The Medial Prefrontal and Orbitofrontal Cortices Differentially Regulate Dopamine System Function , 2011, Neuropsychopharmacology.

[27]  B. Gronier In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptors , 2011, European Neuropsychopharmacology.

[28]  Rune W. Berg,et al.  Influence of Phasic and Tonic Dopamine Release on Receptor Activation , 2010, The Journal of Neuroscience.

[29]  J. Yanofski The dopamine dilemma: using stimulants and antipsychotics concurrently. , 2010, Psychiatry (Edgmont (Pa. : Township)).

[30]  D. Pemberton,et al.  Alternative method of oral dosing for rats. , 2010, Journal of the American Association for Laboratory Animal Science : JAALAS.

[31]  P. Blier,et al.  Relevance of Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder , 2010, CNS neuroscience & therapeutics.

[32]  T. Zetterström,et al.  Age-dependent effects of methylphenidate in the prefrontal cortex: evidence from electrophysiological and Arc gene expression measurements , 2010, Journal of psychopharmacology.

[33]  A. Swann,et al.  Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate , 2009, Brain Research.

[34]  Anthony A Grace,et al.  Entorhinal cortex inhibits medial prefrontal cortex and modulates the activity states of electrophysiologically characterized pyramidal neurons in vivo. , 2009, Cerebral cortex.

[35]  J. Pruessner,et al.  Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate , 2008, Current neuropharmacology.

[36]  E. Szabadi,et al.  Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of Functional Organisation , 2008, Current neuropharmacology.

[37]  E. Szabadi,et al.  Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part II: Physiological and Pharmacological Manipulations and Pathological Alterations of Locus Coeruleus Activity in Humans , 2008, Current neuropharmacology.

[38]  J. Markowitz,et al.  Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? , 2008, Journal of clinical psychopharmacology.

[39]  T. Wilens Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder , 2008, Journal of clinical psychopharmacology.

[40]  A. Swann,et al.  Methylphenidate sensitization is prevented by prefrontal cortex lesion , 2008, Brain Research Bulletin.

[41]  C. Hollis,et al.  Acute dyskinesia on starting methylphenidate after risperidone withdrawal. , 2007, Pediatric neurology.

[42]  M. Kurachi,et al.  Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex , 2007, Synapse.

[43]  S. Sesack,et al.  Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources , 2007, Neuroscience.

[44]  D. S. Zahm,et al.  Glutamatergic Afferents of the Ventral Tegmental Area in the Rat , 2007, The Journal of Neuroscience.

[45]  Wei-Xing Shi,et al.  Behavioral/systems/cognitive Functional Coupling between the Prefrontal Cortex and Dopamine Neurons in the Ventral Tegmental Area , 2022 .

[46]  A. Swann,et al.  Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization , 2007, Brain Research.

[47]  E. Hess,et al.  D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD , 2007, Neurobiology of Disease.

[48]  F. Marshall,et al.  Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain , 2007, Neuropharmacology.

[49]  O. Sabuncuoğlu Risperidone-to-methylphenidate switch reaction in children: three cases , 2006, Journal of psychopharmacology.

[50]  Carmen Moreno,et al.  National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. , 2006, Archives of general psychiatry.

[51]  Charles J. Wilson,et al.  Transient high-frequency firing in a coupled-oscillator model of the mesencephalic dopaminergic neuron. , 2006, Journal of neurophysiology.

[52]  B. Goñi-Allo,et al.  Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats , 2005, Behavioural Brain Research.

[53]  G. Bernardi,et al.  Actions of methylphenidate on dopaminergic neurons of the ventral midbrain , 2005, Biological Psychiatry.

[54]  W. Shi,et al.  Psychostimulants Induce Low-Frequency Oscillations in the Firing Activity of Dopamine Neurons , 2004, Neuropsychopharmacology.

[55]  R. Shen,et al.  Methylphenidate Restores Ventral Tegmental Area Dopamine Neuron Activity in Prenatal Ethanol-Exposed Rats by Augmenting Dopamine Neurotransmission , 2004, Journal of Pharmacology and Experimental Therapeutics.

[56]  J. Bolam,et al.  Uniform Inhibition of Dopamine Neurons in the Ventral Tegmental Area by Aversive Stimuli , 2004, Science.

[57]  D. Hanck,et al.  Molecular Action of Lidocaine on the Voltage Sensors of Sodium Channels , 2003, The Journal of general physiology.

[58]  A. Phillips,et al.  Modulation by Central and Basolateral Amygdalar Nuclei of Dopaminergic Correlates of Feeding to Satiety in the Rat Nucleus Accumbens and Medial Prefrontal Cortex , 2002, The Journal of Neuroscience.

[59]  Antonio Pisani,et al.  Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors , 2002, Neuropsychopharmacology.

[60]  Harold Alan Pincus,et al.  National trends in the outpatient treatment of depression. , 2002, JAMA.

[61]  M. Jackson,et al.  Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens , 2001, Journal of neurochemistry.

[62]  M. Millan,et al.  S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. , 2001, The Journal of pharmacology and experimental therapeutics.

[63]  T. Svensson,et al.  Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. , 2001, The Journal of pharmacology and experimental therapeutics.

[64]  S. Sesack,et al.  Projections from the Rat Prefrontal Cortex to the Ventral Tegmental Area: Target Specificity in the Synaptic Associations with Mesoaccumbens and Mesocortical Neurons , 2000, The Journal of Neuroscience.

[65]  Susan G. Amara,et al.  Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor , 2000, Biological Psychiatry.

[66]  B. Bunney,et al.  Dual Effects of d-Amphetamine on Dopamine Neurons Mediated by Dopamine and Nondopamine Receptors , 2000, The Journal of Neuroscience.

[67]  S. Floresco,et al.  Reversible lesions of the rhinal cortex produce delayed non‐matching‐to‐sample deficits in rats , 2000, Neuroreport.

[68]  B. Bunney,et al.  Endogenous DA‐mediated feedback inhibition of DA neurons: Involvement of both D1‐ and D2‐like receptors , 2000, Synapse.

[69]  Y Li,et al.  Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations , 1999, Synapse.

[70]  S. Cannon,et al.  The Position of the Fast-Inactivation Gate during Lidocaine Block of Voltage-gated Na+ Channels , 1999, The Journal of general physiology.

[71]  P. Overton,et al.  Burst firing in midbrain dopaminergic neurons , 1997, Brain Research Reviews.

[72]  P. Kalivas,et al.  Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine , 1997, Neuroscience.

[73]  Marc A Sommer,et al.  Effective spread and timecourse of neural inactivation caused by lidocaine injection in monkey cerebral cortex , 1997, Journal of Neuroscience Methods.

[74]  J. Tepper,et al.  Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo , 1997, The Journal of Neuroscience.

[75]  S. Sara,et al.  Inhibitory influence of frontal cortex on locus coeruleus neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[76]  F. Gonon,et al.  Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo , 1993, Neuroscience Letters.

[77]  D. Clark,et al.  Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons. , 1993, The Journal of pharmacology and experimental therapeutics.

[78]  T. Svensson,et al.  Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. , 1993, European journal of pharmacology.

[79]  G Chouvet,et al.  Tonic Activation of NMDA Receptors Causes Spontaneous Burst Discharge of Rat Midbrain Dopamine Neurons In Vivo , 1993, The European journal of neuroscience.

[80]  L. Chiodo,et al.  Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons , 1992, Brain Research.

[81]  R. Roth,et al.  Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[82]  John H. Martin Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat , 1991, Neuroscience Letters.

[83]  D. Weinberger,et al.  Ibotenic acid lesions of the medial prefrontal cortex potentiate FG-7142-induced attenuation of exploratory activity in the rat , 1990, Pharmacology Biochemistry and Behavior.

[84]  T. Svensson,et al.  Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. , 1989, Acta physiologica Scandinavica.

[85]  F. Gonon Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry , 1988, Neuroscience.

[86]  P. Johansen,et al.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[87]  Menek Goldstein,et al.  Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area , 1986, Brain Research.

[88]  J. Yeh,et al.  Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. , 1985, Biophysical journal.

[89]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[90]  A. Grace,et al.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization , 1983, Neuroscience.

[91]  L. Swanson,et al.  The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat , 1982, Brain Research Bulletin.

[92]  W. Nauta,et al.  Efferent connections of the substantia nigra and ventral tegmental area in the rat , 1979, Brain Research.

[93]  Barbara E. Jones,et al.  Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study , 1977, Brain Research.

[94]  K. Courtney Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. , 1975, The Journal of pharmacology and experimental therapeutics.

[95]  E. M. Miller Dopamine and Glutamate Dysfunction in a Rodent Model of Attention-Deficit/Hyperactivity Disorder: Implications for Future Neuropharmacology , 2014 .

[96]  N. Dafny,et al.  Acute and chronic dose–response effect of methylphenidate on ventral tegmental area neurons correlated with animal behavior , 2013, Journal of Neural Transmission.

[97]  P. Blier,et al.  Electrophysiological Effects of Repeated Administration of Agomelatine on the Dopamine, Norepinephrine, and Serotonin Systems in the Rat Brain , 2013, Neuropsychopharmacology.

[98]  P. Overton,et al.  Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex , 2005, Journal of Neural Transmission.

[99]  H. Simon,et al.  Anatomical relationships between the ventral mesencephalic tegmentum — A 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques , 2005, Journal of Neural Transmission.

[100]  G. Aston-Jones,et al.  Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat , 2005, Journal of Neural Transmission / General Section JNT.

[101]  Davide Viggiano,et al.  Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling , 2004, Neural plasticity.

[102]  W. Catterall Molecular mechanisms of gating and drug block of sodium channels. , 2002, Novartis Foundation symposium.

[103]  J. Fellous,et al.  A Roles of Dopamine , 2002 .

[104]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .